We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
501
Brown & Brown
BRO
$23.7B
$29.8M 0.03%
523,480
+66,464
+15% +$3.89M
IWS icon
502
iShares Russell Mid-Cap Value ETF
IWS
$16B
$29.8M 0.03%
282,908
+65,707
+30% +$6.89M
SNX icon
503
TD Synnex
SNX
$20.5B
$29.7M 0.03%
313,965
+23,105
+8% +$2.16M
EME icon
504
Emcor
EME
$36.2B
$29.7M 0.03%
200,677
-5,072
-2% -$720K
VONE icon
505
Vanguard Russell 1000 ETF
VONE
$8.69B
$29.7M 0.03%
170,369
+16,481
+11% +$2.89M
APA icon
506
APA Corp
APA
$14.2B
$29.6M 0.03%
634,489
+109,223
+21% +$4.89M
IWP icon
507
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
$29.5M 0.03%
353,161
+32,308
+10% +$2.72M
KHC icon
508
Kraft Heinz
KHC
$29.3B
$29.5M 0.03%
723,547
+249,824
+53% +$9.49M
MTB icon
509
M&T Bank
MTB
$36.4B
$29.3M 0.03%
201,953
-43,166
-18% -$7.1M
ESGU icon
510
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$29.3M 0.03%
345,564
-40,904
-11% -$3.49M
VV icon
511
Vanguard Morningstar Large-Cap ETF
VV
$54.6B
$29.1M 0.03%
167,188
+57,533
+52% +$10.1M
ALC icon
512
Alcon
ALC
$36.9B
$28.9M 0.03%
421,657
-70,939
-14% -$4.53M
EFG icon
513
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$28.9M 0.03%
344,693
+64,928
+23% +$5.25M
RY icon
514
Royal Bank of Canada
RY
$295B
$28.8M 0.03%
306,569
-20,627
-6% -$1.95M
CHE icon
515
Chemed
CHE
$7.23B
$28.8M 0.03%
56,392
+2,664
+5% +$1.3M
IUSV icon
516
iShares Core S&P US Value ETF
IUSV
$27.9B
$28.7M 0.03%
406,984
+124,030
+44% +$8.62M
XBI icon
517
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$28.5M 0.03%
343,615
+53,758
+19% +$4.35M
IYH icon
518
iShares US Healthcare ETF
IYH
$3.78B
$28.4M 0.03%
499,960
+42,195
+9% +$2.33M
BJ icon
519
BJs Wholesale Club
BJ
$12.2B
$28.3M 0.03%
428,345
+49,373
+13% +$3.58M
FNF icon
520
Fidelity National Financial
FNF
$12.8B
$28.2M 0.03%
750,925
-134,867
-15% -$5.06M
FNV icon
521
Franco-Nevada
FNV
$46.3B
$28.2M 0.03%
206,713
+2,207
+1% +$291K
HWM icon
522
Howmet Aerospace
HWM
$114B
$28.2M 0.03%
715,617
+6,560
+0.9% +$239K
DAR icon
523
Darling Ingredients
DAR
$9.9B
$28.1M 0.03%
449,292
-80,909
-15% -$5.71M
TEAM icon
524
Atlassian
TEAM
$39B
$28.1M 0.03%
218,409
-27,334
-11% -$4.35M
CTRA
525
DELISTED
Coterra Energy
CTRA
$28M 0.03%
1,139,921
-59,944
-5% -$1.65M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.